Climaco John M's Form 4 filing
CNS Pharmaceuticals, Inc. (CNSP) · filed Feb 6, 2024
- Accession no.
- 0001683168-24-000705
- Filed
- Feb 6, 2024, 10:27 AM ET
- Trade date
- Feb 1, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $50.0K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Climaco John MCIK 0001546797 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Common stock | PPurchaseAcquired | +166,666 | $0.30 | +$49,999.8 | 215,676 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Common Stock | AGrant or awardAcquired | +166,666 | – | – | 226,867 | Direct | |
| Feb 1, 2024 | Common Stock | AGrant or awardAcquired | +166,666 | – | – | 393,533 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.